Arbeitsgruppe MDS Publikationsliste
Iron Overload in Myelodysplastic Syndromes (MDS) – Diagnosis, Treatment and Response Criteria: a Proposal of the Austrian MDS-Platform
P. Valent, O. Krieger, R. Stauder, F. Wimazal, T. Nösslinger, W.R. Sperr, H. Sill, P. Bettelheim, M. Pfeilstöcker. Iron Overload in Myelodysplastic Syndromes (MDS) – Diagnosis, Treatment and Response Criteria: a Proposal of the Austrian MDS-Platform. 2008. Eur J Clin Invest, Mar,38(3):143-9
Impact of Age and Comorbidity in Myelodysplastic Syndroms
R.Stauder, Th. Noesslinger, M. Pfeilstöcker, W.R. Sperr, F. Wimazal, O. Krieger, P. Valent. Impact of Age and Comorbidity in Myelodysplastic Syndroms. J Natl Compr Canc Netw. 2008 Oct;6(9):927-934
Individualized management and therapy of myelodysplastic syndromes
R. Stauder, F. Wimazal, T. Nösslinger, O. Krieger, W.R. Sperr, H. Sill, M. Pfeilstöcker, P. Valent. Individualized management and therapy of myelodysplastic syndromes. Wiener Klinische Wochenschrift, 2008, 120:523-537
Workshop of the German-Austrian Working Group für Studying Prognostic Factors in Myelodysplastic Syndromes
Valent P, Hofmann WK, Büsche G, Sotlar K, Horny HP, Haase D, Haferlach T, Kern W, Bettelheim P, Baumgartner C, Sperr WR, Nösslinger T, Wimazal F, Giagounidis AA, Lübbert M, Krieger O, Kolb HJ, Stauder R, Pfeilstöcker M, Gattermann N, Fonatsch C, Aul C, Germing U. Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group für Studying Prognostic Factors in Myelodysplastic Syndromes. Ann Hematol. 2009 Jan.16
Comorbidity as Prognostic Variable in MDS: Comparative Evaluation of the HCT-CI and CCI in a Core Data Set of 582 Patients of the Austrian MDS Platform
W.R. Sperr, F. Wimazal, M. Kundi, C. Baumgartner, T. Nösslinger, A. Makrai, R. Stauder, O. Krieger, M. Pfeilstöcker, P. Valent. Comorbidity as Prognostic Variable in MDS: Comparative Evaluation of the HCT-CI and CCI in a Core Data Set of 582 Patients of the Austrian MDS Platform. Annals of Oncology, 2009, in press.
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes
T. Nösslinger, H. Tüchler, U. Germing, W.R. Sperr, O. Krieger, D. Haase, M. Lübbert, R. Stauder, A. Giagounidis, P. Valent, M. Pfeilstöcker. Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes. Annals of Oncology, 2009, in press.